Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T19:45:32.843Z.
Calculation as of: 2026-10-06T19:45:32.843Z.
Quote observation: 2026-10-06T19:44:27.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 1aa4897ea94b4447735fa2b7e4a8bb5a18d1bcefabda34b81af7232f4abbcb6a
EARNINGS YIELD
N/A
Market Cap
$6.65M
Earnings Yield
N/A
TTM Avg
2.14%
3Y Avg
1.65%
5Y Avg
1.48%
Market Cap
$6.76M
Earnings Yield
N/A
TTM Avg
0.03%
3Y Avg
0.01%
5Y Avg
0.01%
Market Cap
$6.77M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aclarion, Inc. (ACON) | $6.64M | N/A | N/A | N/A | N/A |
| Enveric Biosciences, Inc. (ENVB)vs › | $6.65M | N/A | 2.14% | 1.65% | 1.48% |
| Biomerica, Inc. (BMRA)vs › | $6.54M | N/A | 0.84% | 1.16% | 1.47% |
| Ensysce Biosciences, Inc. (ENSC)vs › | $6.76M | N/A | 0.03% | 0.01% | 0.01% |
| Exicure, Inc. (XCUR)vs › | $6.82M | N/A | N/A | N/A | N/A |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.87M | N/A | N/A | N/A | N/A |
| Curanex Pharmaceuticals Inc Common Stock (CURX)vs › | $6.77M | N/A | N/A | N/A | N/A |
| Femasys Inc. (FEMY)vs › | $6.31M | N/A | N/A | N/A | N/A |
| KALA BIO, Inc. (KALA)vs › | $6.99M | N/A | N/A | N/A | N/A |
| Co-Diagnostics, Inc. (CODX)vs › | $7.03M | N/A | 21.79% | 16.65% | 16.65% |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute